INMB INmune Bio Inc. - Common stock
$1,43
Fiyat · May 20, 2026
Temel veriler itibarıyla May 7, 2026
52 Haftlık Aralık
$1–$12
3% of range
Analist Derecelendirmesi
BUY
10 analysts
Fiyat Hedefi
$7
+389% upside
P/E (TTM)
-0.8
ROE
-175.3%
Net Kâr Marjı
-91866.0%
INMB Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.43
Piyasa Değeri
$41M
P/E (TTM)
-0.8
EPS (TTM)
$-1.86
Gelir (TTM)
$50.0K
Temettü Verimi
—
ROE
-175.3%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$1 – $12
INMB Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$50.0K
2020-12-31
→
2025-12-31
Hisse Başına Kâr
$-1.86
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
$-24M
2025-12-31
→
2025-12-31
Marjlar
-91866.0%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
INMB
Akran Ortalaması
P/E (TTM)
-0.8
0.9
P/S (TTM) (F/S (TTM))
829.5
13.4
P/B (F/D)
1.8
1.4
Price / FCF (Fiyat / Serbest Nakit Akışı)
-1.8
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
INMB
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-94766.0%
—
Net Profit Margin (Net Kâr Marjı)
-91866.0%
-391.3%
ROA
-127.8%
-69.9%
ROE
-175.3%
-65.6%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
INMB
Akran Ortalaması
Current Ratio (Cari Oran)
3.6
4.2
Quick Ratio (Cari Oran)
3.5
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
INMB
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
257.1%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-48.9%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
35.4%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
INMB
Akran Ortalaması
INMB Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
10 analist
- Güçlü Al 2 20,0%
- Al 7 70,0%
- Tut 1 10,0%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
4 analist · 2026-05-15
Medyan
$7.50
Ortalama
$7.00
← Tüm hedeflerin altında
$1.43
Düşük
$4.00
Yüksek
$9.00
Medyan hedef
$7.50
+424,3%
Ortalama hedef
$7.00
+389,4%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.05%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.20 | $-0.21 | 0.01% |
| 31 Aralık 2025 | $-0.20 | $-0.27 | 0.07% |
| 30 Eylül 2025 | $-0.24 | $-0.33 | 0.09% |
| 30 Haziran 2025 | $-1.05 | $-0.39 | -0.66% |
| 31 Mart 2025 | $-0.43 | $-0.48 | 0.05% |
| 31 Aralık 2024 | $-0.40 | $-0.55 | 0.15% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| INMB | $41M | -0.8 | 257.1% | -91866.0% | -175.3% | — |
| PSTV | $71M | -1.8 | -10.5% | -429.4% | -636.9% | — |
| TVGN | — | — | — | — | — | — |
| ATOS | $5M | -0.1 | — | — | -71.7% | — |
| LITS | $16M | -1.0 | 33.8% | — | -81.7% | — |
| RNXT | — | -2.6 | 2511.6% | — | — | — |
| LTRN | — | -1.9 | — | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $50.0K | $14.0K | $155.0K | $374.0K | $181.0K | $11.0K | |
| R&D Expense | $21M | $33M | $20M | $17M | $21M | $6M | |
| SG&A Expense | $10M | $9M | $10M | $9M | $9M | $6M | |
| Operating Expenses | $47M | $43M | $30M | $26M | $29M | $12M | |
| Operating Income | $-47M | $-43M | $-30M | $-26M | $-29M | $-12M | |
| Interest Expense | · | $357.0K | $2M | $2M | · | · | |
| Other Non-op | $1M | $553.0K | $-267.0K | $-1M | $-1M | $129.0K | |
| Pretax Income | $46M | $42M | $30M | · | · | · | |
| Net Income | $-46M | $-42M | $-30M | $-27M | $-30M | $-12M | |
| EPS (Basic) | $-1.86 | $-2.11 | $-1.67 | $-1.52 | $-1.88 | · | |
| EPS (Diluted) | $-1.86 | $-2.11 | $-1.67 | $-1.52 | $-1.88 | · | |
| Shares (Basic) | 24,757,545 | 19,944,304 | 17,980,791 | 17,927,327 | 16,130,539 | · | |
| Shares (Diluted) | 24,757,545 | 19,944,304 | 17,980,791 | 17,927,327 | 16,130,539 | · | |
| EBITDA | $-47M | $-43M | · | $-26M | $-29M | $-12M |
Bilanço 21
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $21M | $36M | $52M | $75M | $22M | |
| Receivables | $4M | $1M | $2M | · | · | · | |
| Prepaid Expense | $595.0K | $331.0K | $2M | $4M | $14.0K | $220.0K | |
| Current Assets | $30M | $23M | $40M | $65M | $83M | $24M | |
| PP&E (Net) | $955.0K | · | · | · | · | · | |
| Accum. Depreciation | $87.0K | · | · | · | · | · | |
| Intangibles | · | $17M | $17M | $17M | $17M | $17M | |
| Other Non-current Assets | $595.0K | $79.0K | $131.0K | $99.0K | $99.0K | · | |
| Total Assets | $32M | $40M | $57M | $82M | $100M | $41M | |
| Accounts Payable | $8M | $7M | $8M | $5M | $4M | $2M | |
| Current Liabilities | $8M | $7M | $18M | $11M | $4M | $2M | |
| Capital Leases | $411.0K | $244.0K | $397.0K | $526.0K | $284.0K | $126.0K | |
| Total Liabilities | $9M | $7M | $19M | $22M | $20M | $2M | |
| Long-term Debt | · | $15M | · | $15M | $15M | · | |
| Common Stock | $27.0K | $22.0K | $18.0K | $18.0K | $18.0K | $13.0K | |
| Paid-in Capital | $233M | $196M | $159M | $152M | $144M | $72M | |
| Retained Earnings | $-209M | $-163M | $-121M | $-91M | $-64M | $-33M | |
| AOCI | $-737.0K | $-575.0K | $-799.0K | $-699.0K | $1.0K | $11.0K | |
| Stockholders' Equity | $24M | $32M | $37M | $60M | $80M | $39M | |
| Liabilities + Equity | $32M | $40M | $57M | $82M | $100M | $41M | |
| Shares Outstanding | 26,585,258 | 22,280,451 | 17,950,776 | 17,945,995 | 17,843,303 | 13,481,283 |
Nakit Akışı 9
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $8M | $7M | $7M | $5M | $3M | |
| Operating Cash Flow | $-23M | $-33M | $-12M | $-23M | $-29M | $-9M | |
| CapEx | $1M | · | · | · | · | · | |
| Investing Cash Flow | $-1M | · | · | · | $-15M | · | |
| Stock Issued | $28M | $28M | $775.0K | $699.0K | $80M | $25M | |
| Net Stock Activity | $28M | $28M | · | $699.0K | $80M | $25M | |
| Financing Cash Flow | $28M | $18M | $-4M | $729.0K | $96M | $24M | |
| Net Change in Cash | $4M | $-15M | $-16M | $-23M | $53M | $15M | |
| Free Cash Flow | $-24M | · | · | · | · | · |
Kârlılık 6
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -94766.0% | -304535.7% | · | -6938.8% | -16106.6% | -112016.1% | |
| Net Margin | -91866.0% | -300585.7% | · | -7299.2% | -16762.4% | -110838.8% | |
| Pretax Margin | 91866.0% | 300585.7% | · | · | · | · | |
| EBITDA Margin | -94766.0% | -304535.7% | · | -6938.8% | -16106.6% | -112016.1% | |
| ROA | -127.8% | -87.2% | · | -30.0% | -43.2% | -37.2% | |
| ROE | -175.3% | -118.9% | · | -44.1% | -36.0% | -30.3% |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 3.1 | · | 5.9 | 19.0 | 13.5 | |
| Quick Ratio | 3.5 | 3.1 | · | 4.8 | 17.2 | 12.4 | |
| Interest Coverage | · | -54.0 | · | · | · | · |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 0.0 | 0.0 | · | · | · | · |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 257.1% | -91.0% | -58.6% | 106.6% | 1545.5% | · | |
| Revenue CAGR 3Y | -48.9% | -57.4% | 141.5% | · | · | · | |
| Revenue CAGR 5Y | 35.4% | · | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $50.0K | $14.0K | $155.0K | $374.0K | $181.0K | $11.0K | |
| Net Income TTM | $-46M | $-42M | $-30M | $-27M | $-30M | $-12M | |
| Market Cap | $41M | $104M | · | $114M | $182M | $232M | |
| P/E | -0.8 | -2.2 | -6.7 | -4.2 | -5.4 | · | |
| P/S | 829.5 | 7432.1 | · | 304.2 | 1005.5 | 21104.3 | |
| P/B | 1.8 | 3.2 | · | 1.9 | 2.3 | 6.0 | |
| P / Tangible Book | 1.8 | 6.7 | 9.7 | 2.6 | 2.9 | 10.4 | |
| P / Cash Flow | -1.8 | -3.1 | · | -5.0 | -6.4 | -26.0 | |
| P / FCF | -1.8 | · | · | · | · | · | |
| Earnings Yield | -119.2% | -45.2% | -14.8% | -24.0% | -18.4% | · |
Gelir Tablosu 13
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $0 | · | · | $50.0K | $0 | · | · | $14.0K | $28.0K | $43.0K | $46.0K | $38.0K | $97.0K | $98.0K | $16.0K | |
| R&D Expense | $4M | $2M | $5M | $6M | $8M | $7M | $10M | $7M | $9M | $6M | $6M | $4M | $4M | $3M | $5M | $4M | |
| SG&A Expense | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $6M | $5M | $7M | $25M | $10M | $9M | $12M | $10M | $11M | $8M | $9M | $6M | $6M | $6M | $8M | $6M | |
| Operating Income | $-6M | $-5M | $-7M | $-25M | $-10M | $-9M | $-12M | $-10M | $-11M | $-8M | $-9M | $-6M | $-6M | $-6M | $-7M | $-6M | |
| Interest Expense | · | · | · | · | $0 | · | $145.0K | $250.0K | $357.0K | $467.0K | $568.0K | $631.0K | $612.0K | · | · | · | |
| Other Non-op | $405.0K | $210.0K | $961.0K | $113.0K | $166.0K | $249.0K | $193.0K | $119.0K | $-8.0K | $-29.0K | $-35.0K | · | · | · | · | · | |
| Net Income | $-5M | $-5M | $-6M | $-24M | $-10M | $-9M | $-12M | $-10M | $-11M | $-8M | $-9M | $-7M | $-7M | $-6M | $-8M | $-7M | |
| EPS (Basic) | $-0.20 | $-0.14 | $-0.24 | $-1.05 | $-0.43 | $-0.40 | $-0.60 | $-0.50 | $-0.61 | $-0.47 | $-0.48 | $-0.36 | $-0.36 | $-0.32 | $-0.43 | $-0.38 | |
| EPS (Diluted) | $-0.20 | $-0.14 | $-0.24 | $-1.05 | $-0.43 | $-0.40 | $-0.60 | $-0.50 | $-0.61 | $-0.47 | $-0.48 | $-0.36 | $-0.36 | $-0.32 | $-0.43 | $-0.38 | |
| Shares (Basic) | 26,585,258 | -47,622,359 | 26,585,258 | 23,298,455 | 22,496,191 | -37,575,168 | 20,185,676 | 19,307,323 | 18,026,473 | -35,919,494 | 18,008,295 | 17,945,995 | 17,945,995 | -35,834,948 | 17,945,995 | 17,945,995 | |
| Shares (Diluted) | 26,585,258 | -47,622,359 | 26,585,258 | 23,298,455 | 22,496,191 | -37,575,168 | 20,185,676 | 19,307,323 | 18,026,473 | -35,919,494 | 18,008,295 | 17,945,995 | 17,945,995 | -35,834,948 | 17,945,995 | 17,945,995 | |
| EBITDA | $-6M | · | $-7M | $-25M | $-10M | · | $-12M | $-10M | $-11M | · | $-9M | $-6M | $-6M | · | $-7M | $-6M |
Bilanço 22
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | $25M | $28M | $33M | $19M | $21M | $34M | $31M | $26M | $36M | $42M | $48M | $51M | $52M | $57M | $61M | |
| Receivables | $479.0K | $4M | $2M | $2M | $1M | $1M | $1M | $3M | · | $2M | · | · | · | · | · | · | |
| Prepaid Expense | $694.0K | $595.0K | $472.0K | $505.0K | $207.0K | $331.0K | $864.0K | $1M | $1M | $2M | $2M | $3M | $35.0K | $4M | $5M | $4M | |
| Current Assets | $23M | $30M | $31M | $36M | $21M | $23M | $36M | $35M | $30M | $40M | $46M | $53M | $57M | $65M | $67M | $71M | |
| PP&E (Net) | $903.0K | $955.0K | $878.0K | $706.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | $87.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | · | · | · | · | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | |
| Other Non-current Assets | $683.0K | $595.0K | $746.0K | $570.0K | $49.0K | $79.0K | $82.0K | $81.0K | $106.0K | $131.0K | $129.0K | $130.0K | $99.0K | $99.0K | $99.0K | $99.0K | |
| Total Assets | $26M | $32M | $33M | $38M | $38M | $40M | $53M | $52M | $47M | $57M | $63M | $70M | $74M | $82M | $84M | $88M | |
| Accounts Payable | $5M | $8M | $7M | $8M | $7M | $7M | $11M | $9M | $9M | $8M | $4M | $2M | $2M | $5M | $3M | $2M | |
| Current Liabilities | $5M | $8M | $7M | $9M | $8M | $7M | $14M | $15M | $17M | $18M | $14M | $13M | $10M | $11M | $7M | $2M | |
| Capital Leases | $806.0K | $411.0K | $623.0K | $231.0K | $201.0K | $244.0K | $284.0K | $322.0K | $360.0K | $397.0K | $430.0K | $463.0K | $498.0K | $526.0K | $607.0K | $645.0K | |
| Total Liabilities | $6M | $9M | $8M | $9M | $8M | $7M | $14M | $15M | $18M | $19M | $18M | $19M | $19M | $22M | $20M | $18M | |
| Long-term Debt | · | · | · | $15M | $15M | · | · | · | · | · | $12M | $15M | $15M | $15M | $15M | $15M | |
| Total Debt | · | · | · | · | · | · | $2M | $5M | $7M | · | · | · | · | · | · | · | |
| Common Stock | $27.0K | $27.0K | $27.0K | $27.0K | $23.0K | $22.0K | $22.0K | $20.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | |
| Paid-in Capital | $235M | $233M | $230M | $227M | $203M | $196M | $194M | $179M | $161M | $159M | $157M | $155M | $154M | $152M | $150M | $148M | |
| Retained Earnings | $-214M | $-209M | $-204M | $-197M | $-173M | $-163M | $-154M | $-142M | $-132M | $-121M | $-113M | $-104M | $-98M | $-91M | $-85M | $-77M | |
| AOCI | $-727.0K | $-737.0K | $-764.0K | $-763.0K | $-610.0K | $-575.0K | $-1M | $-713.0K | $-669.0K | $-799.0K | $-735.0K | $-712.0K | $-708.0K | $-699.0K | $-1M | $-701.0K | |
| Stockholders' Equity | $20M | $24M | $25M | $29M | $30M | $32M | $39M | $36M | $28M | $37M | $44M | $51M | $55M | $60M | $64M | $70M | |
| Liabilities + Equity | $26M | $32M | $33M | $38M | $38M | $40M | $53M | $52M | $47M | $57M | $63M | $70M | $74M | $82M | $84M | $88M | |
| Shares Outstanding | 26,585,258 | 26,585,258 | 26,585,258 | 26,585,258 | 22,930,411 | 22,280,451 | 22,172,451 | 19,706,732 | 17,950,776 | 17,950,776 | 17,945,995 | 17,945,995 | 17,945,995 | 17,945,995 | 17,945,995 | 17,945,995 |
Nakit Akışı 8
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-3M | $-3M | $-5M | $-7M | $-7M | $-11M | $-7M | $-8M | $-7M | $-3M | $-4M | $-3M | $-1M | $-6M | $-3M | $-5M | |
| CapEx | · | $143.0K | $193.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | · | $-143.0K | $-193.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | $0 | $0 | $22M | $5M | $0 | $12M | · | · | $0 | · | · | · | $0 | $0 | $0 | |
| Net Stock Activity | · | · | · | · | $5M | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | · | $67.0K | $0 | $22M | $5M | $-2M | $10M | $13M | $-2M | $-2M | · | · | · | $0 | $0 | $0 | |
| Net Change in Cash | $-3M | $-3M | $-6M | $14M | $-2M | $-13M | $2M | $5M | $-10M | $-6M | $-6M | $-3M | $-1M | $-5M | $-4M | $-6M |
Kârlılık 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -19810.0% | · | · | · | -78692.9% | · | -19832.6% | -13937.0% | -16902.6% | · | -7594.9% | -39925.0% | |
| Net Margin | · | · | · | · | -19478.0% | · | · | · | -78750.0% | · | -19914.0% | -14132.6% | -17200.0% | · | -7882.6% | -42737.5% | |
| EBITDA Margin | · | · | · | · | -19810.0% | · | · | · | -78692.9% | · | -19832.6% | -13937.0% | -16902.6% | · | -7594.9% | -39925.0% | |
| ROA | -17.0% | · | -15.0% | -54.3% | -23.0% | · | -20.9% | -16.0% | -18.2% | · | -11.7% | -8.2% | -7.8% | · | -8.1% | -9.2% | |
| ROE | -21.9% | · | -20.2% | -75.1% | -33.6% | · | -29.3% | -22.4% | -26.4% | · | -15.9% | -10.8% | -10.0% | · | -10.2% | -12.1% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.2 | · | 4.2 | 4.2 | 2.6 | · | 2.6 | 2.4 | 1.7 | · | 3.2 | 4.0 | 5.5 | · | 9.7 | 30.9 | |
| Quick Ratio | 0.1 | · | 4.0 | 4.1 | 2.6 | · | 2.5 | 2.3 | 1.5 | · | 2.9 | 3.7 | 5.0 | · | 8.3 | 26.8 | |
| Debt / Equity | · | · | · | · | · | · | 0.1 | 0.1 | 0.3 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | -84.7 | -39.5 | -30.9 | · | · | · | · | · | · | · |
Verimlilik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | 0.1 | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 12
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | $141.0K | $141.0K | $141.0K | · | $225.0K | $198.0K | $315.0K | · | $291.0K | · | |
| Net Income TTM | $-46M | · | $-53M | $-56M | $-43M | · | $-41M | $-36M | $-33M | · | $-29M | $-28M | $-28M | · | $-31M | $-30M | |
| Market Cap | $30M | · | $55M | $61M | $179M | · | $120M | $174M | $211M | · | $121M | $163M | $116M | · | $111M | $159M | |
| Enterprise Value | · | · | · | · | · | · | $88M | $148M | $192M | · | · | · | · | · | · | · | |
| P/E | -0.6 | · | -0.9 | -0.9 | -3.6 | · | -2.5 | -4.5 | -6.5 | · | -4.2 | -5.9 | -4.1 | · | -3.5 | · | |
| P/S | · | · | · | · | · | · | 847.6 | 1232.7 | 1495.9 | · | 540.0 | 823.0 | 368.0 | · | 382.4 | · | |
| P/B | 1.5 | · | 2.2 | 2.1 | 6.0 | · | 3.1 | 4.8 | 7.5 | · | 2.8 | 3.2 | 2.1 | · | 1.7 | 2.3 | |
| P / Tangible Book | 1.5 | · | 2.2 | 2.1 | 13.6 | · | 5.4 | 8.8 | 18.0 | · | 4.4 | 4.8 | 3.0 | · | 2.4 | 3.0 | |
| P / Cash Flow | -8.8 | · | · | · | -26.2 | · | · | · | -28.2 | · | · | · | -101.6 | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | -7.2 | -15.0 | -17.5 | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | 627.3 | 1047.7 | 1364.4 | · | · | · | · | · | · | · | |
| Earnings Yield | -169.9% | · | -112.1% | -111.7% | -27.4% | · | -40.6% | -22.1% | -15.4% | · | -24.1% | -16.9% | -24.1% | · | -28.2% | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $50.0K | $14.0K | $155.0K | $374.0K | $181.0K |
| Faaliyet Kâr Marjı % | -94766.0% | -304535.7% | — | -6938.8% | -16106.6% |
| Net Gelir | $-46M | $-42M | $-30M | $-27M | $-30M |
| Seyreltilmiş Hisse Başı Kâr | $-1.86 | $-2.11 | $-1.67 | $-1.52 | $-1.88 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 3.6 | 3.1 | — | 5.9 | 19.0 |
| Cari Oran | 3.5 | 3.1 | — | 4.8 | 17.2 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-24M | — | — | — | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.